Saundra L. Pelletier

Chief Executive Officer, Evofem Biosciences, Inc.

Companies

Aditxt, Inc.Board member Jun 9, 2025 to now¹
WINDTREE THERAPEUTICS INC /DE/Board member Aug 14, 2024 to now²
Evofem Biosciences, Inc.Board member Jan 18, 2018 to Apr 26, 2023³
Evofem Biosciences, Inc.Chief executive officer Jan 18, 2018 to Apr 26, 2023³
Tracon Pharmaceuticals, Inc.Board member Mar 18, 2020 to Apr 21, 2023⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Evofem Biosciences, Inc. EVFM186,722 shares⁵$1.3K at $0.01Dec 31, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 31, 2022Returned to company 50,000 shares of Evofem Biosciences, Inc.⁵
May 27, 2022Bought 141,000 shares at $0.35 of Evofem Biosciences, Inc.⁶
Feb 18, 2022Granted 750,000 shares of Evofem Biosciences, Inc.⁷
Dec 31, 2021Returned to company 300,000 shares of Evofem Biosciences, Inc.⁸
Dec 20, 2021Bought 135,000 shares at $0.38 of Evofem Biosciences, Inc.⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAditxt, Inc., Board member
2
SEC EDGARWINDTREE THERAPEUTICS INC /DE/, Board member
3
SEC EDGAREvofem Biosciences, Inc., Board member
4
SEC EDGARTracon Pharmaceuticals, Inc., Board member
5
SEC EDGAREvofem Biosciences, Inc. shares after the filing of Dec 31, 2022
6
SEC EDGARForm 4 filed May 31, 2022
7
SEC EDGARForm 4 filed Feb 23, 2022
8
SEC EDGARForm 4 filed Jan 4, 2022
9
SEC EDGARForm 4 filed Dec 20, 2021